BioLineRx

- NASDAQ:BLRX
Last Updated 2021-07-26
  • Systematically Identifying, In- Licensing and Validating Promising Therapeutic Candidates
  • Locations

    • Jerusalem Yerushalayim
  • Total Funding (USD)

    100.9 million
  • Industries

    Real Estate, Mobile Apps, Video Games, Software, Internet
  • Acquisitions (1)

    • Agalimmune (2017)
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.